AlphAIAlphAI — Financial news for AI agents
finance.yahoo.com$AFRM

Affirm’s (NASDAQ:AFRM) Q3 CY2026: strong sales but stock drops 10.4%

Affirm (AFRM) reported Q3 CY2026 revenue of $1.26B, up 35.2% YoY, beating estimates. EPS of $0.47 also exceeded expectations. Guidance for Q4 was $1.45B, slightly above consensus. Despite strong results, shares dropped 10.4%.

Original reporting
finance.yahoo.com
Published Nov 5, 2026, 10:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 10:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Affirm’s (NASDAQ:AFRM) Q3 CY2026: strong sales but stock drops 10.4% — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$AFRMBearishHigh
01

Why it matters

The earnings surprise combined with a guidance outlook above consensus created a mixed signal, prompting a sell‑off.

02

Market read

First‑report earnings with a double‑digit price move for a mid‑cap fintech; high relevance for traders.

03

What to watch

Potential upside from upcoming partnership announcements and a possible shift in monetary policy could improve margins.

Relevance 9/10Novelty 9/10Timing: immediate post‑earnings

Background

Affirm's Q3 CY2026 earnings beat expectations on revenue and EPS, yet the stock fell sharply.

Company-level read

Ticker impact

$AFRMBearishHigh confidence
Context

Affirm reported Q3 CY2026 revenue and EPS beats but shares dropped 10.4% after the release.

Expected impact

downward pressure as investors react to weaker guidance and higher‑than‑expected growth expectations

Evidence & confidence

Despite beating estimates, the stock fell 10% on concerns over future growth and higher‑cost environment for BNPL lenders.

Market effects

Sector

Financials/BNPL segment may face heightened scrutiny on credit risk and growth outlook.

Regional

U.S. markets could see a modest pullback in fintech‑related stocks.

Global

Limited to investors with exposure to U.S. consumer‑finance equities.

Counterpoint

What could challenge this read

The beat suggests underlying demand remains strong; the price drop may be an over‑reaction offering a buying opportunity.

Key entities

  • company
    Affirm Holdings Inc.

    Buy‑now‑pay‑later fintech firm.

Read at source← All news

StoryAffirm Q1 FY2027 earnings beat but shares slide on credit concerns and lower price targets

Also covered by

4 outlets

Related articles

$AFRMHighAI 8/10

Affirm Posts Its Best Quarter Ever as Visa and Mastercard Wobble

Affirm reported fiscal Q1 2027 earnings with GAAP EPS of $0.47, beating estimates, and revenue of $1.26B, up 35% YoY. Gross merchandise volume rose 34% to $14.4B. The company raised its full-year outlook, citing strong growth in its card services and active users. Affirm's performance contrasts with declines in Visa and Mastercard shares amid stablecoin concerns.

startupfortune.com
$AFRMMed

Affirm (AFRM) Q1 2027 Earnings Call Transcript

Affirm (AFRM) executives discussed growth prospects, funding costs, and agentic shopping during Q1 2027 earnings call. Max Levchin expects 30%+ growth for a long time, citing low e-commerce penetration. Robert O'Hare confirmed a 30% growth floor for the year. Levchin also highlighted Affirm's focus on agentic shopping, emphasizing personalized transaction pricing. Funding costs rose 27 bps quarter-over-quarter but remain down year-on-year, with 70% of on-balance sheet funding fixed-rate.

finance.yahoo.com
$AFRMMed

Piper Sandler lowers Affirm stock price target to $105 on valuation

Piper Sandler cut its price target on Affirm (AFRM) to $105 from $115, citing valuation changes, while raising its fiscal 2027 EPS estimate to $1.92. Affirm's Q1 results beat expectations with $1.26B revenue and $0.47 EPS, but shares fell 8% after-hours. Analysts note potential upside, with revenue growth of 32% and predicted profitability. Other analysts raised targets to $97 (Scotiabank) and $100 (Needham).

investing.com
$AFRMHigh

Scotiabank raises Affirm stock price target to $97 on growth outlook

Scotiabank raised its price target on Affirm (AFRM) to $97 from $95, maintaining a Sector Outperform rating. The fintech company reported 30% gross merchandise volume growth, a 4.3% transaction cost take rate, and raised its fiscal 2027 growth floor to 30%. Affirm's Q1 2027 earnings beat expectations with $0.47 EPS on $1.26B revenue. Management noted increased allowance rates and delinquencies but highlighted better loan sale pricing.

investing.com